Study of 540,000 IBD Patient Visits Shows Opioids Given to 58% with Worst Pain

San Diego, CA (May 18-21, 2019) – Boston Strategic Partners, Inc., a global life sciences consulting firm, presented the poster Opioid Usage and Patient-Reported Pain Scores in Inflammatory Bowel Disease Patients: A Retrospective Analysis of a Large U.S. Electronic Health Record Database at Digestive Disease Week (DDW) 2019.

The poster featured visualization of treatment pathways and pain outcomes, where patient flows are depicted in full-color, easily understood diagrams. The goal of the study was to examine opioid usage and pain scores for patients suffering from IBD, stratified by type of visit. The study sourced data from Cerner Health Facts®, a comprehensive source of de-identified, real-world data. The poster was presented by Apeksha V. Shenoy, Senior Healthcare Consultant.

Click here to view the poster.

About the Conference

DDW is the largest and most prestigious meeting in the world for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world. In 2019, DDW commemorated its 50th year as the premier meeting in gastroenterology, hepatology and surgery.  DDW is jointly sponsored by four societies: American Association for the Study of Liver Diseases (AASLD); American Gastroenterological Association (AGA); American Society for Gastrointestinal Endoscopy (ASGE); and Society for Surgery of the Alimentary Tract (SSAT).

About BSP

Founded in 2003, Boston Strategic Partners, Inc. is a dedicated healthcare and life sciences company. BSP offers five different types of services:

  • Business & Clinical Strategy
  • Health Economics & Outcomes Research (HEOR)
  • Medical Communications
  • Regulatory Strategy
  • Financial Advisory

For more information or to schedule a meeting with our team, please email